iBio Provides Update on Development of Next-Gen COVID-19 Vaccine Candidate

Go back to iBio Provides Update on Development of Next-Gen COVID-19 Vaccine Candidate
IBIO, Inc. (NASDAQ: IBIO) Delayed: 1.67 +0.08 (5.03%)
Previous Close $1.59    52 Week High $0.80 
Open $1.60    52 Week Low $0.34 
Day High $1.68    P/E N/A 
Day Low $1.57    EPS $-0.08 
Volume 1,512,077